SubodhVermaMD Profile Banner
Subodh Verma Profile
Subodh Verma

@SubodhVermaMD

Followers
1K
Following
1K
Media
205
Statuses
1K

Cardiac Surgeon, St Michael's Hospital | Canada Research Chair in Cardiovascular Surgery | Professor, University of Toronto | Associate Editor, JTCVS

Toronto, Ontario
Joined March 2023
Don't wanna be here? Send us removal request.
@SubodhVermaMD
Subodh Verma
3 years
Hi Twitter! 👋 I’m Dr. Subodh Verma, a #cardiac surgeon-scientist at St Michael's Hospital (@UnityHealthTO), Professor at @uoftmedicine, and a Canada Research Chair (#CRC) in Cardiovascular Surgery. Looking forward to joining the conversation on #CardioTwitter!🫀
29
17
288
@Shahzad77891064
Shahzad Raja
9 days
"Breaking News! @SubodhVermaMD announces the imminent release of the new AHA/ACC Secondary Prevention after CABG guidelines at the 11th ICC in New York! Stay tuned for expert insights on optimizing post-CABG care #CABGGuidelines #ICC2025" @Coronary4front @SubodhVermaMD
0
3
10
@Shahzad77891064
Shahzad Raja
9 days
"Legendary experts shaping the future of coronary care! "Visions from Giants" session at #ICC2025 is redefining the landscape of coronary disease management. Don't miss the insights!
0
2
10
@ahmedawadmd
Ahmed Awad, MD
7 days
A refreshing reminder from Dr. @SubodhVermaMD to often-missed cornerstone of CABG. CABG isn’t just anatomy and grafts; optimizing GMT and antilipidemic therapy is just as crucial in tackling CAD. 🫀📈 @ISCAScoronary #CardiacSurgery #ISCAS #ICC2025
0
1
16
@SubodhVermaMD
Subodh Verma
7 days
Coronary Artery Bypass Graft Failure in Women: Incidence and Clinical ...
0
0
4
@TheLancet
The Lancet
8 days
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial https://t.co/H1Kb3FKp3j
1
19
71
@TheLancet
The Lancet
9 days
The rise of ultra-processed foods is damaging public health, fuelling chronic diseases worldwide, and deepening health inequalities. Urgent, coordinated global action is needed to address the UPF challenge. Find out more in an Editorial ➡️ https://t.co/6hBuTB5XCv
18
235
455
@GianTorre610
Gianluca Torregrossa
7 days
With more than 570 attendees, @ISCAScoronary #ICC2025 define itself as the best coronary surgery meeting in the World. From a Live #TECAB to lively discussion on #Afib #TTfM and #HF CABG to the keynote speech of @DrOz, ICC has set a new standard in the CT surgical meetings.
1
5
25
@EricTopol
Eric Topol
9 days
How do the metabolic waste products get cleared from our brain? And how does this process intersect with the brain's immune system? An exceptional review by @jonykipnis and colleagues @NeuroCellPress https://t.co/zS5VSOlcZa
10
207
888
@SubodhVermaMD
Subodh Verma
9 days
Great to see Dr Naresh Trehan at the International corner meeting in New York today and thanks to him for chairing the plenary session. ⁦@medanta⁩ ⁦@DLBHATTMD
1
0
8
@SubodhVermaMD
Subodh Verma
9 days
What a great coronary meeting with Greg stone presenting
0
0
6
@SubodhVermaMD
Subodh Verma
9 days
0
0
4
@SubodhVermaMD
Subodh Verma
14 days
1
1
8
@SubodhVermaMD
Subodh Verma
17 days
Effects of semaglutide in obesity-related heart failure with preserved ejection fraction across the age spectrum: Findings from the STEP-HFpEF programme
Tweet card summary image
link.sosido.com
CONCLUSION: In patients with HFpEF enrolled across the STEP-HFpEF and STEP-HFpEF DM trials, treatment with...
0
0
2
@hvanspall
Harriette Van Spall, MD MPH 🇨🇦
19 days
Wonderful to welcome Dr Subodh Verma to share his expertise in #PAD with us at @MacDeptMed Cardiology Regional Grand Rounds 8 am EST Tuesday, November 25 2025 Via Teams #CardiometabolicDisease #CVD #VascularDisease
1
1
13
@ehj_ed
EHJ Editor-in-Chief
22 days
A must-read paper in #EHJ! Coronary revascularization: a long-term perspective. A State-of-the-Art review forecasting advancements by 2040, drawing on historical trends and recent breakthroughs. @escardio @ESC_Journals #CardioTwitter https://t.co/2I8oeozR6s
6
104
260
@braadypark
Brady Park
3 months
Honoured to have presented the primary results of the SEMA-VR CardioLink-15 translational study as a late-breaker at #ESCCongress Big thank you to my supervisors @SubodhVermaMD @DavidHessLab and @escardio for the opportunity Out now on @ehj_ed https://t.co/S6YLYgSAzX
0
2
8
@SubodhVermaMD
Subodh Verma
22 days
Great IMCVP meeting
1
1
8